Armata Pharmaceuticals (ARMP) Net Income: 2013-2018
Historic Net Income for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.
- Armata Pharmaceuticals' Net Income rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 63.16%. This contributed to the annual value of -$53.2 million for FY2024, which is 22.71% down from last year.
- Latest data reveals that Armata Pharmaceuticals reported Net Income of -$1.1 million as of Q4 2018, which was up 60.27% from -$2.8 million recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' Net Income registered a high of -$779,000 during Q3 2017, and its lowest value of -$11.3 million during Q1 2014.
- For the 3-year period, Armata Pharmaceuticals' Net Income averaged around -$3.9 million, with its median value being -$3.1 million (2016).
- As far as peak fluctuations go, Armata Pharmaceuticals' Net Income tumbled by 691.25% in 2014, and later skyrocketed by 76.61% in 2017.
- Over the past 5 years, Armata Pharmaceuticals' Net Income (Quarterly) stood at -$2.6 million in 2014, then dropped by 10.40% to -$2.9 million in 2015, then crashed by 250.75% to -$10.1 million in 2016, then soared by 76.61% to -$2.4 million in 2017, then surged by 53.19% to -$1.1 million in 2018.
- Its last three reported values are -$1.1 million in Q4 2018, -$2.8 million for Q3 2018, and -$9.7 million during Q2 2018.